Long-Term Olanzapine Treatment in Children With Autism
Status:
Completed
Trial end date:
2011-10-01
Target enrollment:
Participant gender:
Summary
This study will determine the short- and long-term safety and effectiveness of the drug
olanzapine (Zyprexa®) for reducing symptoms of autism in children.